Galdu-irabazien kontua
AMPHASTAR PHARMACEUTICALS, INC.
AMPH
Errendimenduaren laburpena
Egin klik taulako edozein lerrotan grafikoan gehitzeko
milioika USDtan
| Neurria | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Diru-sarrerak
|
719.89 | 731.97 | 644.40 | 498.99 | 437.77 | 349.85 | 322.36 | 294.67 | 240.18 | 255.17 | 251.52 | 210.46 |
|
Diru-sarreren kostua
|
363.83 | 358.11 | 293.27 | 250.13 | 238.03 | 206.51 | 190.43 | 187.68 | 149.38 | 150.98 | 174.17 | 159.21 |
|
Irabazi gordina
|
356.06 | 373.86 | 367.33 | 256.71 | 209.72 | 151.65 | 136.58 | 113.22 | 96.80 | 106.10 | 77.35 | 52.72 |
|
Ustiapen-gastuak
|
215.65 | 168.44 | 154.13 | 141.36 | 129.85 | 132.39 | 131.96 | 115.61 | 91.69 | 88.50 | 84.25 | 69.24 |
|
Ikerketa eta garapena
|
85.84 | 73.91 | 73.74 | 74.77 | 60.93 | 67.23 | 68.85 | 57.56 | 43.42 | 41.20 | 37.07 | 28.43 |
|
Salmentak, orokorrak eta administratiboak
|
85.93 | 56.72 | 51.54 | 45.06 | 51.43 | 50.38 | 50.28 | 49.89 | 44.46 | 41.83 | 41.50 | 34.81 |
|
Beste ustiapen-gastu batzuk
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
Ustiapen-irabaziak
|
140.40 | 205.42 | 213.19 | 115.35 | 79.86 | 19.26 | 4.61 | -2.39 | 5.11 | 17.60 | -6.90 | -16.52 |
|
Ez-ustiapeneko diru-sarrerak
|
-16.78 | -15.66 | -25.63 | 8.54 | 14.25 | -6.32 | 60.27 | -1.30 | 2.52 | -0.75 | -3.47 | -0.17 |
|
Interesen diru-sarrerak
|
8.68 | 10.61 | 5.46 | 1.32 | 0.60 | 0.64 | 1.00 | 0.46 | 0.43 | 0.27 | 0.32 | 0.24 |
|
Interesen gastuak
|
8.90 | 8.90 | 27.16 | 1.85 | 0.89 | 0.37 | 0.12 | 0.24 | 0.83 | 1.02 | 0.99 | 0.61 |
|
Beste ez-ustiapeneko diru-sarrerak/gastuak
|
0.02 | 0.57 | 2.00 | 1.20 | 0.20 | -6.59 | 59.39 | -1.52 | 2.92 | 0.01 | -2.79 | 0.20 |
|
Zerga aurreko irabazia
|
123.62 | 189.76 | 171.36 | 116.04 | 84.14 | 4.64 | 60.23 | -9.93 | 1.62 | 14.95 | -10.36 | -18.15 |
|
Zerga-gastua
|
25.53 | 30.25 | 33.81 | 24.65 | 22.02 | 3.23 | 11.29 | -4.19 | -2.89 | 4.41 | -7.58 | -7.45 |
|
Partaidetza ez-kontrolatzailea
|
- | - | - | - | 1.19 | -0.31 | -2.43 | -0.92 | - | - | - | - |
|
Irabazi garbia
|
98.09 | 159.52 | 137.55 | 91.39 | 62.12 | 1.40 | 48.94 | -5.74 | 4.51 | 10.53 | -2.79 | -10.70 |
Informazio osagarria
Akzioko datuak, eratorritakoak eta bestelakoak — ez dira galdu-irabazien kontuaren parte
milioika USDtan, bestela adierazi ezean
| Neurria | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Amortizazioa eta balio-galera
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
140.40 | 205.42 | 213.19 | 115.35 | 79.86 | 19.26 | 4.61 | -2.39 | 5.11 | 17.60 | -6.90 | -16.52 |
|
Akzioko irabazia (oinarrizkoa)
|
2.10 | 3.29 | 2.85 | 1.88 | 1.30 | 0.03 | 1.04 | -0.12 | 0.10 | 0.23 | -0.06 | -0.25 |
|
EPS diluitua
|
2.03 | 3.06 | 2.60 | 1.74 | 1.25 | 0.03 | 0.98 | -0.12 | 0.09 | 0.22 | -0.06 | -0.25 |
|
Akzioen batez besteko haztatua
|
46.74 | 48.43 | 48.27 | 48.55 | 47.78 | 47.04 | 46.98 | 46.40 | 46.11 | 45.38 | 44.96 | 41.96 |
|
Akzioen batez besteko haztatu diluitua
|
48.22 | 52.06 | 53.00 | 52.43 | 49.78 | 49.12 | 49.91 | 46.40 | 48.37 | 47.50 | 44.96 | 41.96 |
|
Irabazi globala
|
101.96 | 158.82 | 137.69 | 89.53 | 59.07 | 2.37 | 48.27 | -7.65 | 7.10 | 8.31 | -3.61 | - |